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Abstract Mammalian heart has been reported to express AC 
isozymes (types V and VI) that are inhibited by < ~M [Ca2÷]; 
avian heart has been reported to express adenylyl cyclase activity 
that is inhibited by <ttM [Ca2+]. We have used reverse transcrip- 
tion polymerase chain reaction (RT-PCR) to determine that type 
V and VI AC mRNAs are present in freshly isolated ventricular 
myocytes. Subsequent RNase protection assays revealed that that 
the type V signal is 4-5 times that for the type VI isozyme. In 
situ hybridization with high specific activity cRNA probes com- 
bined with immunocytochemistry with a chick anti-myosin anti- 
body was used to probe the cellular origins of type V and type VI 
AC signals. These studies show that myocytes contain messages 
for both the type V and VI isozymes but that AC V is the major 
isoform. Interestingly, while the type V AC mRNA appears to 
be localized primarily, if not exclusively, in myocytes, the signal 
for type AC VI mRNA in non-myocytes is stronger than in 
myocytes. 
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I. Introduction 
To date at least eight types of mammalian adenylyl cyclase 
isoforms have been cloned and characterized [1-3]. The differ- 
ent adenylyl cyclase (AC) isozymes not only have different 
tissue distributions, but also have type-specific regulatory fea- 
tures including some involving Ca 2+. Type I and VIII AC can 
be markedly stimulated by nanomolar concentrations of Ca2÷/ 
Calmodulin (CAM) [3,4]. mRNAs for types I and VIII AC are 
present at high levels in hippocampus [3,5,6], a region function- 
ally associated with the formation of new memory. Because of 
their tissue distributions, types I and VIII AC have been pro- 
posed to play important roles in development of long term 
potentiation i the hippocampus [3,5,6]. In contrast o type 1 
and VIII adenylyl cyclase, types V and VI AC are inhibited by 
submicromolar concentrations of Ca 2+ [7 10]; Northern blot 
and PCR analyses uggest that these isozymes are the primary 
isozymes expressed in the heart [7,9,11]. Because of their abili- 
ties to be inhibited by submicromolar concentrations of Ca 2÷ 
and their tissue distributions, it is proposed that these forms of 
adenylyl cyclase may provide a key control point in the heart 
for regulating contractility [12,13]. A previous study in our 
laboratory on cultured embryonic hick ventricular myocytes 
demonstrated that increased calcium entry through L-type cal- 
cium channels in response to fl-adrenergic receptor stimulation 
*Corresponding author. Fax: (1) (312) 996 1225. 
E-Mail: U35058@uicvm.uic.edu 
provides asensitive negative inhibition offl-receptor-stimulated 
adenylyl cyclase activity as reflected by measurements of cAMP 
levels [14]. Although we did not measure [Ca2+]i or determine 
the types of adenylyl cyclase in chick cardiac myocytes, our 
data suggested that the feedback inhibition was based on a 
directory inhibitory effect of Ca 2÷ on one or more Ca2+-sensi - 
tive adenylyl cyclase isoforms. In our present study, we report 
that type V is the major isoform in embryonic chick ventricular 
myocytes as indicated by RNase protection assays and in situ 
hybridization studies. Furthermore, in situ hybridization stud- 
ies indicate that type V AC mRNA is localized primarily, if not 
exclusively in myocytes. Interestingly, the in situ hybridization 
studies also show that non-myocytes in the cultures contain a 
strong signal for the type VI isozyme. 
2. Materials and methods 
2.1. RNA isolation and first strand cDNA synthesis 
Myocyte-enriched dissociated cell preparations were prepared from 
ventricles harvested from 13-day chick embryos using standard tech- 
niques [15] and stored in liquid nitrogen until use. Total RNA was 
extracted from the dissociated chick ventricular myocytes by the guani- 
dinium/CsCl gradient method [16] and poly(A) ÷ RNA was isolated 
using oligo(dT)-cellulose spin columns (Clontech, Palo Alto, CA) ac- 
cording to the manufacturers in tructions, lst-strand cDNA was syn- 
thesized using MMLV reverse transcriptase in the presence ofRNasin. 
Twenty-microliter r actions were diluted 5-fold with water, and 1 ,ul 
was used directly as template in PCR reactions. 
2.2. PCR amplification, cloning and DNA sequencing 
Degenerate oligonucleotide primers based on the second conserved 
domain of known mammalian AC sequences were used to amplify 
'myocyte' cDNA [17]. The sense primer corresponds tothe conserved 
amino acid sequence KIKTIG: 5"CGGCAGCTCGAGAA(A/G)AT- 
(ACT)AA(A/G)AC(I)AT(ACT)GGY. The antisense primer corre- 
sponds to the conserved amino acid sequence WG(N/K)TVN: 5'C- 
CGGGACTCGAGAC(A/G)TT(I)AC(I)GT(I)TT(1)CCCCA. This 
primer pair, which has been shown to amplify all known mammalian 
AC isoforms, has XhoI sites (underlined and 6 bp restriction enzyme 
'clamps' at the extreme 5' ends [17]. Agarose gel electrophoresis re-
vealed a single band of ~220 bp which was cloned into pGEM7Z 
(Promega, Madison, WI). Clones with appropriate size XhoI fragments 
were sequenced from both ends using vector (T7 and SP6) primers. 
Sequenase (version 2.0, U.S. Biochemical, Cleveland, OH) was used for 
sequencing reactions for [35S]dATP/autoradiography-based sequenc- 
ing. 
2.3. Preparation of 32p-labelled riboprobes and RNase protection 
assays 
PGEM7Z plasmids containing chick type V or type VI adenylyl 
cyclase sequences were linearized with EcoRI and antisense 32p-labelled 
cRNA probes were generated using the Riboprobe Gemini System Kit 
from Promega (Madison, WI) and [~-32p]UTP (3000 Ci/mmol, ICN, 
lrvine, CA). RNase protection assays were performed according to 
'RNase one' protection protocol from Promega (Madison, WI). The 
protected fragments were analyzed by autoradiography of sequencing 
gels. 
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2.4. In situ hybridization and immunohistochemistry 
PGEM7Z plasmids containing chick type V and type VI adenylyl 
cyclase sequences were linearized with EcoRI to transcribe antisense 
probes, or linearized with XbaI to transcribe sense probes. In vitro 
transcribed 35S-labelled sense and antisense cRNA probes were gener- 
ated as previously described. Final reaction conditions were as de- 
scribed [18]. 
In situ hybridization and immunohistochemistry were performed on 
cells isolated from 11- to 13-day-old embryonic hick ventricles, and 
cultured in a M199-based medium [14] on 0.25% gelatin coated 
coverslips. After 3 days in culture, the cells (myocytes and 'contami- 
nating' non-myocytes) on the coverslips were washed with PBS (phos- 
phate- buffered saline) and fixed for 20 min at room temperature in 
freshly prepared 4% paraformaldehyde in phosphate buffer, pH 7.2. 
The fixation was stopped by washing with 3 x PBS after which the cells 
were washed with PBS. The cells were permeabilized with 0.1% Triton 
X-100 for 5 min, rinsed with PBS twice and incubated with a rat 
monoclonal antibody to chick skeletal muscle myosin heavy chain 
which recognizes cardiac myocyte myosin (c~-MHC; provided by Dr. 
John Kennedy, Dept. of Physiology and Biophysics, University of Illi- 
nois at Chicago) by inverting the coverslip on a drop of primary anti- 
body (1 : 1000) made in PBS containing heparin (3000 unit/ml) for 1 h 
at room temperature. At the end of incubation, the cells were washed 
with PBS three times and incubated with a fluorescent labelled second- 
ary antibody (Texas red-conjugated goat anti-rat IgG) by inverting the 
coverslip on a drop of secondary antibody (1 : 100) made in PBS con- 
taining heparin (3000 unit/ml) for 1 h at room temperature. After three 
washes with PBS, the cells were incubated for 10 min in a solution of 
triethanolamine hydrochloride (0.1 M, pH 8.0), containing 0.25% acetic 
anhydride. The cells were then rinsed with 2 x SSC, and dehydrated 
in a graded ethanol series. Cells were first incubated in a prehybridiza- 
tion buffer for 2 h at room temperature to equilibrate the cells with 
formamide and to block sites of nonspecific binding of the probe. The 
prehybridization buffer was identical to the hybridization buffer with 
the exception that it did not contain the probe. The cells were then 
incubated in hybridization buffer at 45°C overnight. The hybridization 
buffer consisted of: 50% formamide, 2 x SSC, 10% dextran sulfate, 1 x 
Denhardt's olution, 10 mM dithiothreitol, 0.5 mg/ml salmon sperm 
DNA, 0.25 mg/ml yeast RNA and [~-35S]UTP-labelled sense or anti- 
sense probes. After hybridization, the cells were washed twice in 2 x SSC 
at room temperature, washed two times for 15 min in 2 x SSC/50% 
formamide containing I0 mM DTT at 50°C, rinsed twice in 2 x SSC 
at room temperature, and incubated in RNase A (20 ¢tg/ml) (Sigma) in 
digestion buffer (0.5 M NaCI, 10 mM Tris-HC1, 1 mM EDTA, pH 8.0) 
for 30 min at 37°C. The cells were then washed twice in 2 x SSC 
containing 10 mM DTT for 30 min at 50°C, twice in 2 x SSC/50% 
formamide containing 10 mM DTT for 30 rain at 50°C, and twice in 
2 x SSC containing 10 mM DTT at room temperature. The cells were 
dehydrated with a graded series of ethanol solutions containing 0.3 M 
ammonium acetate, and the coverslips were attached to 3 x 1 inch glass 
microscope slides with Permount (Fisher Scientific) and allowed to dry. 
The dried slides were dipped in the dark in a 1 : 1 mixture of NTB-2 
emulsion (Kodak) and distilled water warmed to 42°C. After air drying 
in the dark at room temperature for 2 h, the slides were sealed in 
light-tight boxes and stored at 4°C for 3 weeks. After 3 weeks of 
storage, the slides were developed in Kodak Dektol (2.5 min at 17°C). 
The reaction was stopped in 1% acetic acid for 30 s and the slides were 
fixed in Kodak Rapid Fixer for 3.5 min. The slides were then rinsed in 
running water for 30 min, counterstained with bisbenzmide and 
mounted in 1 : 1 PBS/Glycerol. 
3. Results 
3.1. RT-PCR 
The amplification of reverse transcribed 'myocyte' poly(A) 
RNA with the degenerate primer pair yielded a single band of 
-220  bp when analyzed in an agarose gel. The amplified PCR 
products were isolated, subcloned, and sequenced. Two types 
of adenylyl cyclase sequences (217 bp) were identified. One was 
chick AC V (2 clones) which had 97.2% identity with all current 
known mammal ian type V isoforrns at the amino acid level 
[9-11,19], and 86.1% identity with all current known mammal-  
ian type VI isoforms [7,8,11,20]. The other was chick AC VI (15 
clones), which had 91.7% identity with all current known mam- 
malian type VI isoforms at the amino acid level [7,8,11,20] and 
had 84.7% identity with all current known mammal ian type V 
isoforms [9-11,19]. The identity between the PCR amplified 
sequences of chick AC V and AC VI was 86.1% at the amino 
acid level and 75.1% at the nucleotide acid level. Fig. I shows 
sequence al ignments of chick AC V and AC VI obtained by 
PCR, and with the corresponding dog sequences. Notably, we 
failed to detect messages for any other adenylyl cyclase 
isoforms such as AC IV and AC VII which have been suggested 
to be present in the heart [2,12,21]. Thus, chick ventricular 
myocytes either do not contain AC IV and AC VII mRNA,  or 
chick mRNAs  differ significantly so that the primers do not 
amplify the messages for these adenylyl cyclase isoforms. Con- 
sequently a failure of the primers to amplify other adenylyl 
cyclase isoforms does not prove that the myocytes do not con- 
tain these mRNAs.  As Northern blots or solution hybridization 
have shown that mammal ian brain contains mRNA for all 
types of adenylyl cyclase [1], we decided to use the same primer 
pair and approach to amplify reverse transcribed chick brain 
poly(A) ÷ RNA as a positive control. Our reasoning was that 
if we detected sequences for other adenylyl cyclases in brain 
cDNA but not in heart cDNA, we could conclude with some 
confidence that the failure to detect the messages in the heart 
Chick AC VI STYMAASGLNAATYDREGRSHIAALADYAMQH~IEQMRYINEHSFNNFQMKIGLNMGPVVAGVIGARKPQYDI 
* 
Chick AC V STYMAASGLNI~STYDI(EGI~THIKALADFAMRI/~QMKYINEHSFNNFQMKIGLNIGPVVAGVIGARKPQYDI 
Chick AC V 
Dog AC V 
STYMAASGLNDSTYDKEG KTH IKALADF~YI  NEHSFNNFQMK IGLNIG PWAGVI  GAR K PQYD I
STYMAASGLNDSTYDKVGKTH I KALADFAM~MDQMKY I NEHSFNNFQMK IGLN IG PWAGVIGARK PQYD I
Chick AC VI STYMAASGLNAATYDREGRSHIAALADYAMQH4EQMKYINEHSFNNFQMKIGLNMGPVVAGVIGARKPQYDI 
Dog AC VI STYMAASGLNASTYDQi~GRSHIT~YAMRI~IEQMKI:IINEHSFNNFQMKIGLNMGPVVAGVIGARKPQYDI 
Fig. 1. Alignments of the partial chick amino acid sequences for types V and Vl adenylyl cyclase with each other, and with the corresponding canine 
sequences. Dots demote conservative substitutions; astericks denote more significant alterations. 
H.Z Yu et al./FEBS Letters 374 (1995) 89-94 91 
1 2 3 4 5 6 
Fig. 2. RNase protection assays of chick types V and VI adenylyl 
cyclase mRNAs, tRNA (20 pg; lanes 2 and 5)) or total RNA from 
freshly isolated embryonic chick ventricular myocytes (20 ¢tg; lanes 3 
and 6) was hybridized with type V (lanes 5 and 6) or VI (lane 2 and 3) 
35S-labelled antisense riboprobes, digested, and run on a sequencing gel. 
Undigested types VI and V probes were run in lanes 1 and 4, respec- 
tively. The autoradiogram was developed after 3.5 hours at -70°C. 
against chick muscle myosin heavy chain followed by a fluores- 
cent labeled secondary antibody (Texas red-conjugated goat 
anti-rat IgG), and hybridized with 35S-labelled chick AC V and 
AC VI sense and antisense RNA probes. By using a im- 
munofluorescent/dark-field microscope, and alternating be- 
tween the fluorescent filters and dark-field condenser, both the 
silver grains deposited by the 3SS-labelled probes and myocytes 
stained with Texas red fluorescence were identified so that the 
AC mRNA could be ascribed to myocytes or non-myocytes. 
The nuclei of all cells were visualized by staining with bisben- 
zamide which binds to DNA producing a light blue fluores- 
cence [23]. In order to avoid any bias in interpretation, allslides 
were coded and the code revealed only after examination. In 
one of three experiments wo workers in the laboratory inde- 
pendently characterized 28slides. Eight out of eight slides were 
is most likely because the myocytes do not contain the mRNA. 
Unfortunately, only type VI AC (22 clones) and type I AC (3 
clones) messages were detected in chick brain poly(A) + RNA 
(data not shown). Therefore, we can not conclude with confi- 
dence that chick ventricular myocytes do not contain any other 
adenylyl cyclase isoforms. Importantly, other workers reported 
that type IV and VII mRNAs in rat cardiac tissues are difficult 
to detect by Northern blot analysis using poly(A) ÷ RNA; easily 
detectable l vels of type V and VI mRNAs were reported by 
the same workers [22]. 
3.2. RNase protection assays 
As we did not perform quantitative PCR, our PCR experi- 
ments do not assess the relative abundances of mRNAs. We 
therefore performed RNase protection assays using probes de- 
rived from the type V and VI AC partial clones. The RNase 
protection assays howed that mRNAs for both AC V and VI 
are present in total RNA prepared from freshly isolated chick 
ventricular myocyte preparations, and that the abundance of 
AC V mRNA in 'myocyte' mRNA is -4-  to 5-fold that of AC 
VI as assessed by densitometry analysis (Fig. 2). 
3.3. In situ hybridization/immunocytochemistry 
The PCR and RNase protection assay results lead us to the 
tentative conclusion that 11- to 13-day-old embryonic hick 
ventricular myocytes transcribe the genes for AC V and AC VI. 
However, as the myocyte preparations used to prepare 'my- 
ocyte mRNA' were not 100% pure, we could not be sure that 
the AC V and AC VI detected by PCR and RNase protection 
assays were of myocyte origin. We therefore directly deter- 
mined the cellular origins of the messages in a series of experi- 
ments in which in situ hybridization using high specific activity 
cRNA probes and immunocytochemistry with a chick anti- 
myosin antibody were simultaneously performed on cultured 
cells. 35S-labelled cRNA probes prepared by in vitro transcrip- 
tion provided sufficient sensitivity for these experiments. Cul- 
tured cells were incubated with a rat monoclonal antibody 
Fig. 3. Combined in situ hybridization and immunohistochemistry of 
embryonic hick venricular myocyte culture hybridized with antisense 
(panel A) and sense (panel B) type V adenylyl cyclase riboprobes. 
Double exposures show the silver grain deposits (white dots seen in 
dark field) and myosin filaments (Texas red fluorescence). Panel A 
demonstrates silver deposits over myocytes; panel B shows nonspecific 
deposits of silver grains. A scale bar (30 pm) is shown in the bottom 
of panel B. 
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correctly identified by both observers as samples hybridized 
with sense probes (4 each of type V and VI). Eight of ten and 
seven of ten sides were characterized as having strong signals 
in myocytes; two out of ten and three out of ten of the same 
slides were characterized ashaving strong signals in myocytes 
and weak signals in groups of non-myocytes. These slides were 
later identified as samples hybridized with type V antisense 
probe. Ten out of ten and eight out of ten slides were character- 
ized as having strong signals in non-myocytes and weak signals 
in myocytes. These slides were later identified as samples hy- 
bridized with type VI antisense probe. One observer had no 
comment on 2 slides. Representative photomicrographs are 
shown in Figs. 3 and 4. Fig. 3A,B shows a double exposure 
showing myocyte culture stained with anti-myosin antibody 
and silver grains deposited by 35S-labelled chick AC V antisense 
(panel A) or sense probe (panel B). It is clear that hybridization 
with chick AC V antisense probe yields a strong signal in 
myocytes. Fig. 4A shows a double exposure showing nuclei 
stained with bisbenzamide and silver grains deposited by 35S- 
labelled AC V! antisense probe. Nuclei staining with bisben- 
zamide, shows that the whole cell population (myocytes and 
non-myocytes) has AC VI signal. Fig. 4B shows the same field 
as Fig. 4A, but is a double exposure showing myocytes tained 
with anti-myosin antibody and silver grains deposited by 35S- 
labelled AC VI antisense probe. Fig. 4C shows a double expo- 
sure of myocytes tained with anti-myosin antibody and silver 
grains deposited by 35S-labelled AC VI sense probe. By compar- 
ing Fig. 4A and B, it is clear that there is a strong signal of AC 
VI in non-myocytes. Although the type VI message in the 
myocyte pointed out by the wide arrow in Fig. 4A,B is strong, 
most myocytes did not have a 'clear' type VI signal. While this 
probably reflects a weak signal, the possibility that only a sub- 
population of the myocytes express type VI AC cannot be 
excluded. Moreover, it is not possible to tell if AC VI message 
is expressed in all non-myocytes, or in certain types of non- 
myocytes. Lastly, we occasionally also saw weak signals of AC 
V message xpressed in groups of non-myocytes which ap- 
peared to originate from a single cell. 
4. Discussion 
We previously reported that the cAMP-elevating effect of 
isoproterenol in isolated embryonic hick ventricular myocytes 
is potentiated by calcium channel antagonists, and postulated 
that increases in Ca 2+ following fl-adrenergic receptor stimula- 
tion and activation of adenylyl cyclase acts as a negative feed- 
back regulator of adenylyl cyclase activity [14]. As mammalian 
types V and VI adenylyl cyelase are inhibited by submicromolar 
Ca 2+ concentrations [7-10], and appear to be the maj or adenylyl 
cyclase isozymes expressed in mammalian heart [7,9,11], we 
postulated the embryonic hick myocytes express avian type V 
and/or type VI isozymes [14]. We now report that: (i) RT-PCR 
4-- 
Fig. 4. Combined in situ hybridization and immunocytochemistry of 
embryonic chick ventricular myocyte culture hybridized with antisense 
(panels A and B) and sense (panel C) type VI adenyyl cyclase ribo- 
probes. Panel C shows nonspecific silver deposits with the sense probe, 
Panels A and B show double xposures ofthe same field; panel A shows 
all nuclei as detected by bisbenzamide. Panel B shows myosin fluores- 
cence and 'bleed through' of bisbenzamide fluorescence. The thick 
arrow points out a myocyte with type VI signal: the thin arrow points 
out a non-myocyte with type VI signal. Note that all non-myocytes 
appear to have type VI signal while a strong type VI signal is not evident 
in two myocytes inthe field. A scale bar (30/~m) is shown at the bottom 
of panel C. 
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detects type V and VI messages in mRNA isolated from prep- 
arations of isolated myocytes, and (ii) RNase protection assays 
suggest that type V message in 'myocyte RNA' is 4-5 times that 
of type VI message. Most importantly, this is the first report 
of experiments in which in situ hybridization has been used to 
directly establish the cellular localizations of the adenylyl 
cyclase isozymes in the heart. 
The in situ hybridization experiments clearly establish that 
the embryonic myocytes transcribe the gene for the type V 
isozyme (Fig. 3); it also appears that some myocytes contain 
type VI message (Fig. 4). It may be that all myocytes also 
express type VI AC but that the signal is too weak to identify 
in most cells. It should be remembered that the myocytes are 
embryonic, and that the relative amounts of the two messages 
may vary during development. Northern blots of mRNA pre- 
pared from rat hearts of different ages suggest that the expres- 
sion of type V adenylyl cyclase increases with age while that for 
type VI decreases [22]. As both in situ hybridization and North- 
ern blots measure message, not protein, and mRNA and pro- 
tein are not necessarily directly proportional, measurements of 
the individual isozymes will be needed before their contribu- 
tions to total adenylyl cyclase activity can be evaluated. 
It is also noteworthy that the in situ experiments establish 
that the signal for type VI message is strong in most, if not all, 
non-myocytes (Fig. 4). It should be mentioned that the micro- 
scopic fields shown in Fig. 4 do not give a measure of the 
relative abundance of myocytes vs. non-myocytes but rather 
were chosen to illustrate the strong type VI signal in non- 
myocytes. Although quantitation would be difficult, if not im- 
possible, our impression is that a high percentage of the type 
VI message detected in RNase protection assays may be of 
non-myocyte origin. A direct comparison is not possible as the 
RNase assays were performed on RNA isolated from freshly 
isolated cells while the in situ hybridization experiments were 
performed on cells maintained in culture for three days thus 
allowing for the possibility that contaminating non-myocytes 
had divided thus diminishing the 'purity' of the myocyte prep- 
aration. 
The cascade of reactions by which cardiac fl-adrenergic re- 
ceptors activate adenylyl cyclase to modulate cAMP levels and 
affect intracellular Ca 2÷ concentrations and function has been 
long been recognized [24]. The importance of effects of Ca 2+ 
(not mediated by Ca2+/calmodulin) on adenylyl cyclase and 
subsequently cAMP are only now becoming recognized. The 
importance of these interrelationships in normal and pa- 
thophysiologic states can not be overemphasized, especially in 
view of the use of agents that affect one or the other of these 
systems in the treatment of various cardiomyopathies. For ex- 
ample, while the effects of fl-blockers on [Ca2+]~ are of known 
importance and are, in fact, the basis for their use, it is quite 
possible that indirect effects of calcium channel blockers on 
cAMP production could contribute to therapeutic or toxic ef- 
fects of these agents, especially when agents that affect both 
systems are concurrently administered. While we have not iden- 
tified the non-myocytes in our cultures as endothelial or smooth 
muscle cells, or as fibroblasts, the expression of a Ca2+-inhibita - 
ble adenylyl cyclase in some of these cells suggests that other 
important interactions may occur. For example, if some of the 
non-myocytes that contain the type VI message are vascular 
smooth muscle cells, then an indirect effect on adenylyl cyclase 
(inhibition) via an elevation in intracellular Ca 2+ could contrib- 
ute to a vasoconstriction in response to a-adrenergic receptor 
stimulation. 
In addition to different issue/cell distributions, the type V 
and VI isozymes appear to be regulated ifferently by PKC. 
The type V isozyme is markedly activated by in vitro 
phosphorylations catalyzed by protein kinase C isozymes [25]. 
While similar experiments with type VI AC have not been 
reported, type VI AC transiently expressed in the human em- 
bryonic kidney 293 cell line is not affected by the treatment with 
phorbol ester [26]. This apparent difference, coupled with our 
finding that the myocytes transcribe primarily the type V gene, 
may be related to the sensitization of adenylyl cyclase that 
occurs shortly after myocardial ischemia [27]. It has been re- 
ported that adenylyl cyclase is sensitized in acute myocardial 
ischemia by a PKC-mediated mechanism, and that this sensiti- 
zation contributes to the malignant arrhythmias associated 
with acute ischemia, i.e. myocardial infarction [28]. Somewhat 
paradoxically, PKC activation has also recently been impli- 
cated in cardiac preconditioning which is believed to be medi- 
ated by adenosine receptors that couple to the inhibition of 
adenylyl cyclase [29]. Obviously, much remains to be learned 
about the complex crosstalk which occurs between Ca 2+ and 
cAMP signalling systems in the heart. 
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